Duesseldorf (ots) - - Gerresheimer among the top 5% of assessed businesses - Total score increases to 72/100 points - Status demonstrates consistent implementation of CSR strategy Gerresheimer, an innovative provider of systems and solutions and a global partner for the pharma, biotech, and cosmetic industries, has once again been awarded Gold status by the ratings agency EcoVadis. EcoVadis assesses the performance of ...
Duesseldorf (ots) - - Gerresheimer presents an extensive portfolio of containment solutions, drug delivery systems and digital therapy support - High-quality ready-to-fill solutions for biopharmaceuticals, cell and gene therapy - EcoDesign and environmentally friendly packaging options ensure greater sustainability Gerresheimer, an innovative system and solution ...
Düsseldorf (ots) - - First-quarter revenues grew organically by 21.0% - Adjusted EBITDA up organically by 24.8% - Gerresheimer confirms guidance for financial year 2023 Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug ...
Duesseldorf (ots) - - Consistent execution of strategy and strong fourth quarter performance has resulted in organic revenue growth of 16.2% for FY 2022 - Organic growth in adjusted EBITDA of 10.2% for FY 2022, ahead of guidance - Q4 2022 delivered ...
Düsseldorf (ots) - Gerresheimer AG, the leading global provider of healthcare, beauty, and drug delivery systems for pharma, biotech, and cosmetics, today announced a joint venture with Corning Incorporated (NYSE: GLW), a leading innovator in materials science and manufacturing, to increase global access to the ...
Düsseldorf (ots) - At today’s Capital Markets Day, Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, reaffirmed its growth agenda and increased its revenue and adjusted ...
Düsseldorf, Germany / Piombino Dese, Italy (ots) - Gerresheimer AG, a leading global provider of healthcare & beauty and drug delivery systems for pharma, biotech and cosmetics and Stevanato Group S.p.A. (NYSE: STVN), a global provider of drug containment, drug delivery and diagnostic solutions to the ...
Düsseldorf (ots) - Gerresheimer AG, a leading provider of healthcare solutions and drug delivery systems for pharma, biotech and cosmeticsand Merck, Darmstadt, a leading science and technology company, jointly developed a digital twin solution to further ensure traceability and trust in crucial steps along the pharmaceutical supply chain. The proof of concept aims to ...
Duesseldorf (ots) - - Organic revenue growth of 17.4% in the third quarter supported by continued strong demand for High Value Solutions - Organic adjusted EBITDA up 13.3% - Gerresheimer firmly on track to deliver on FY 2022 guidance Gerresheimer AG, a leading provider of healthcare & beauty solutions ...
Düsseldorf, Germany / Piombino Dese, Italy (ots) - - Two leading companies joined forces to develop a new Ready-To-Use solution platform based on EZ-fill® pre-sterilized platform - Seamless integration into standard fill & finish lines - Significant increase in quality and efficiency Gerresheimer AG, a leading ...
Düsseldorf/Zandt (ots) - Gerresheimer AG and Zollner Elektronik AG are pooling their market-leading pharmaceutical and medical technology expertise under a strategic partnership. Starting immediately, they will offer pharmaceutical, healthcare and biotech companies their conceptual design, development and ...
Morganton, NC (ots) - - Major expansion in the North American market - Supported by U.S. Biomedical Advanced Research and Development Authority (BARDA) via 70/30 cost-share cooperative agreement - New state-of-the-art forming lines in North Carolina increase annual production capacity for Glass Vials in the U.S. significantly Gerresheimer AG, a leading provider of ...
Duesseldorf/Kuopio (ots) - - Partners join forces to improve lives of millions of Parkinson’s patients worldwide with a transformative technology-based solution - Gerresheimer participates in seed-round of the Finnish MedTech company and university spin-off - Monitoring and personalized medication adjustment in ...
Duesseldorf (ots) - The Annual General Meeting of Gerresheimer AG has approved the payment of a dividend of EUR 1.25 per share for the 2021 financial year. This represents a payout ratio of 30 percent. “2021 was a record year for us. Our formula G strategy process and the investments in transforming our ...
Duesseldorf/Kosamba (ots) - Gerresheimer has significantly ramped up its glass and plastic production capacities in India to satisfy its global pharma customer needs. A new modern plant to produce high quality plastic containers and closures was built at the Kosamba site, and glass production received a new ...
Duesseldorf, Germany/Cambridge, Mass (ots) - - Partners are developing needle-free drug delivery platform for biologics and biosimilars - This Innovative solution improves patient’s quality of life, especially for people with chronic diseases - Partners will together expand their client base, product range and IP ...
